These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1386264

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Propionibacterium acnes resistance: a worldwide problem.
    Eady EA, Gloor M, Leyden JJ.
    Dermatology; 2003; 206(1):54-6. PubMed ID: 12566805
    [Abstract] [Full Text] [Related]

  • 25. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
    Luk NM, Hui M, Lee HC, Fu LH, Liu ZH, Lam LY, Eastel M, Chan YK, Tang LS, Cheng TS, Siu FY, Ng SC, Lai YK, Ho KM.
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
    [Abstract] [Full Text] [Related]

  • 26. Erythromycin-resistance of cutaneous bacterial flora in acne.
    Dreno B, Reynaud A, Moyse D, Habert H, Richet H.
    Eur J Dermatol; 2001 Jan; 11(6):549-53. PubMed ID: 11701406
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris.
    Vogt K, Hermann J, Blume U, Gollnick H, Hahn H, Haustein UF, Orfanos CE.
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):943-5. PubMed ID: 1486893
    [Abstract] [Full Text] [Related]

  • 31. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
    Gloor M, Lamerz A, Franke-Hoffman M.
    Zentralbl Bakteriol A; 1981 Feb; 248(4):502-8. PubMed ID: 6452774
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
    Sugisaki H, Yamanaka K, Kakeda M, Kitagawa H, Tanaka K, Watanabe K, Gabazza EC, Kurokawa I, Mizutani H.
    J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N, Hernandez PO, Tyring SK, Haitz KA, Motta A.
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [Abstract] [Full Text] [Related]

  • 36. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies.
    Dessinioti C, Katsambas AD.
    Clin Dermatol; 2010 Jun; 28(1):2-7. PubMed ID: 20082942
    [Abstract] [Full Text] [Related]

  • 37. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
    Popovic S, Urbán E, Lukic M, Conlon JM.
    Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
    Eady EA, Cove JH, Holland KT, Cunliffe WJ.
    Br J Dermatol; 1989 Jul; 121(1):51-7. PubMed ID: 2527056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.